22NW LP's Q2 2024 13F: 1 new position, 1 exit

Form 13F-HR for the quarter ended Jun 30, 2024 · filed Aug 14, 2024 · 13 reported positions · accession 0001214659-24-014708

What changed this quarter

22NW LP's changes in reported equity positions, Q2 2024
Activity Security Weight before Weight now Change Shares Shares %
Exited ORION S.A. (OEC) 6.9% — −6.9 pts −339K sh −100%
New DHI GROUP INC (DHX) — 3.7% +3.7 pts +2.07M sh new

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:

  • STRATA SKIN SCIENCES INC (SSKN): 86272A206 → 86272A305, 5.37M → 537K shares (share count change consistent with a stock split)

Top 10 positions — 95.7% of the equity book

Changes in the top 10 this quarter: DHX entered · OEC left

# Security Weight before Weight now
1 FOSTER L B CO (FSTR) 30.9% 24.1%
2 LIFECORE BIOMEDICAL INC (LFCR) 8.0% 20.5%
3 ANEBULO PHARMACEUTICALS INC (ANEB) 13.3% 12.5%
4 STERLING INFRASTRUCTURE INC (STRL) 9.5% 10.1%
5 BARRETT BUSINESS SVCS INC (BBSI) 7.2% 7.4%
6 CULP INC (CULP) 5.1% 4.7%
7 PHENIXFIN CORP (PFX) 4.5% 4.7%
8 FARMER BROS CO (FARM) 6.0% 4.5%
9 DHI GROUP INC (DHX) 0.0% 3.7% Entered the top 10
10 MANITOWOC CO INC (MTW) 4.3% 3.5%
— ORION S.A. (OEC) 6.9% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).